Lamivudine Suppliers & Bulk Manufacturers
Available Forms: Tablet & Oral solution
Available Strengths: Tab:150 mg, 300 mg; Oral solution:10 mg/mL
Reference Brands: Epivir®(US/EU)
Category:
Anti Viral
Lamivudine Tablets (100 mg–300 mg) are used to treat HIV and Hepatitis B. PharmaB2B connects global buyers with WHO-GMP and USFDA-approved suppliers for bulk, compliant procurement. Ideal for tenders and institutional use, Lamivudine ensures accessible, high-quality treatment in public health programs.
Lamivudine is available in Tablet & Oral solution
and strengths such as Tab:150 mg, 300 mg; Oral solution:10 mg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Lamivudine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Lamivudine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Lamivudine Tablets are essential antiretrovirals used in the treatment of HIV-1 and chronic Hepatitis B infection. Available in 100 mg, 150 mg, and 300 mg strengths, Lamivudine is part of the WHO Essential Medicines list and widely used in global ART programs. On PharmaB2B platforms, healthcare buyers and procurement agencies can source Lamivudine in bulk from WHO-GMP and USFDA-approved manufacturers. Ideal for NGOs, hospitals, and government tenders, Lamivudine is available as both standalone and fixed-dose combination therapy. Connect with trusted suppliers for quality-assured, cost-effective ARV solutions to support HIV and HBV care worldwide.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing